Diagnostic Stewardship: Beyond Managing Bloodstream InfectionsFebruary 21st 2020
Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.
Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?February 19th 2020
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportFebruary 18th 2020
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back AgainFebruary 13th 2020
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Consider the MIC: Treating Respiratory Infections Caused by Pseudomonas aeruginosa With Ceftolozane/TazobactamFebruary 12th 2020
When using ceftolozane/ tazobactam to treat patients with P aeruginosa respiratory tract infections, the use of extended or continuous antibiotic infusion and/or combination therapy with other active antibiotic agents should be considered, particularly if targeting higher MIC values.
The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day ReadmissionsFebruary 11th 2020
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
Clinical Characteristics of the First 2019-nCoV Cases in Wuhan, ChinaJanuary 24th 2020
A new article published in The Lancet features information on epidemiology, laboratory, and radiology elements of the first 41 cases of the novel coronavirus confirmed in Wuhan, China.
Can Improving Penicillin Allergy Documentation Cut Costs?December 18th 2019
A team of pharmacists at Baptist Hospital reported that improving penicillin allergy documentation and increasing the use of β-lactams had potential cost savings of $21,468 over a 3-month period.
Speed of Processing Training Resulted in Significant Improvements for Individuals With HANDNovember 8th 2019
There is a vast unmet need for non-pharmacological treatment strategies to protect and improve cognitive function in the approximately 50% of adults living with HIV who experience HIV-associated neurocognitive disorder.